Aequs approves ₹6.5 billion preferential warrant issue to promoter investor
As filed · The Board of Directors of Aequs Limited, at their meeting held today i.e. Friday, September 25, 2026, inter alia, approved the preferential issue of warrants convertible into equity shares of the Comp
What happened
FactAequs’s Board approved the preferential issue of up to 28,071,690 warrants to Mellwood Trustee Services Private Limited, trustee of Melligeri Private Family Foundation, at ₹231.55 per warrant. The issue remains subject to shareholder and other required approvals, with an EGM scheduled for October 22, 2026.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedThe five-year plan we presented in June contemplates capital expenditure of approximately USD 350 to 450 million between FY 2026-27 and FY 2030-31.
We signed a Memorandum of Understanding with the Government of Tamil Nadu setting out our intent to invest ₹1,900 crore over ten years at Hosur, towards an integrated ecosystem for aero-engine and landing-gear components.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
- We expect the utilization to improve over the course of the year as the ramp progresses. (management committed by FY27)
- These developments provide a stronger foundation for continued improvement through the remainder of FY’27. (management committed by FY27)
Evidence
- Aequs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026.(opens the original filing in a new tab)
- Earlier statement · FY26
- Latest statement · FY26
- Earlier statement · FY26
How CapitSignal classified this
- Reasoning:
- The proposed transaction could provide Aequs with up to INR 6,499,999,819.50, but the warrants and any resulting equity shares depend on shareholder, stock exchange and other required approvals, as well as payment of the balance exercise consideration.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%